Current status of diabetes treatment

Southern Medical Journal

Volumn 95, Issue 1, 2002, Pages 24-29

  Bell, David S H ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; C PEPTIDE; CYANOCOBALAMIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; REPAGLINIDE; SULFONYLUREA DERIVATIVE; SULFONYLUREA RECEPTOR; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; VASCULOTROPIN;

ANEMIA; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; DIABETIC DIET; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FAMILY HISTORY; FLATULENCE; FLUID RETENTION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEART PROTECTION; HIGH RISK POPULATION; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RESISTANCE; INSULIN TREATMENT; KINESIOTHERAPY; LACTIC ACIDOSIS; LIVER TOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0036162295     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200201000-00006     Document Type: Review

References (39)

1. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: The SOS interevention study
2. Advances in therapy for type 2 diabetes
3. Role and management of exercise in diabetes mellitus
4. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus
5. Oral hypoglycemic agents
6. Glucophage: An effective and safe agent for initial monotherapy in patients with non-insulin-dependent diabetes mellitus
7. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus
8. Treatment of insulin resistance with peroxisome proliferator activated receptor gamma agonists
9. Biguanides and NIDDM
10. Weight loss in patients treated with a metformin sulfonylurea combination in comparison with twice daily mixed insulin
11. Differing effects of thiazolidinediones on LDL and HDL subfractions and Lp(a)
12. Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes mellitus
13. Expression and function of PP AR gamma in rat and human vascular smooth muscle cells
14. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes
15. Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin-dependent diabetes mellitus: A serial intravascular ultrasound study
16. Prudent utilization of the present available treatment modalities for type 2 diabetes
17. New pharmacological approaches to glycemic control
18. C-peptide utilization in clinical practice: Effects on treatment and outcome of diabetes in a series of cases
19. Tissue triglyceride levels in type 2 diabetes and the role of thiazolidinediones in reversing the effects of tissue hypertriglyceridemia: Review of the evidence in animals and humans
20. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
21. Glycated hemoglobin, diabetes and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
22. Using combination therapy for type 2 diabetes
23. Outcome of metformin-facilitated reinitiation of oral diaetic therapy in insulin-treated patients with non-insulin-dependent diabetes mellitus
24. Improved glycemic control with use of oral hypoglycemia therapy with or without insulin
25. How long can insulin be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?
26. Is avoiding insulin therapy an achievable and worthwhile goal?
27. Triple oral antidiabetic therapy in type 2 diabetes mellitus
28. Long-term efficacy of triple oral therapy for type 2 diabetes mellitus
29. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes
30. Rapid insulin initiation in non-insulin-dependent diabetes mellitus
31. Improved postprandial glycemic control with insulin aspart in type 2 diabetic patients treated with insulin
32. Effects of metformin in patients with poorly controlled insulin-treated type 2 diabetes mellitus
33. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens
34. Improved postprandial glycemic control with insulin aspart: A randomized double-blind crossover trial in type 1 diabetes
35. Reduction of postprandial hyperglycemia in IDDM patients on insulin analog treatment
36. Insulin pump therapy for the '90s
37. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy